Risk Stratification of Pancreatic Ductal Adenocarcinoma Patients Undergoing Curative-Intent Surgery after Neoadjuvant Therapy

被引:1
|
作者
Yang, Hyun Kyung [1 ]
Park, Mi-Suk [1 ]
Han, Kyunghwa [2 ,3 ]
Eom, Geonsik [4 ]
Chung, Yong Eun [1 ]
Choi, Jin-Young [1 ]
Bang, Seungmin [5 ]
Kang, Chang Moo [6 ]
Seong, Jinsil [7 ]
Kim, Myeong-Jin [1 ]
机构
[1] Yonsei Univ, Severance Hosp, Dept Radiol, Coll Med, Seoul, South Korea
[2] Yonsei Univ, Res Inst Radiol Sci, Dept Radiol, Coll Med, Seoul, South Korea
[3] Yonsei Univ, Ctr Clin Imaging Data Sci, Coll Med, Seoul, South Korea
[4] Yonsei Univ, Dept Med, Coll Med, Seoul, South Korea
[5] Yonsei Univ, Severance Hosp, Inst Gastroenterol, Dept Internal Med,Coll Med, Seoul, South Korea
[6] Yonsei Univ, Severance Hosp, Pancreatobiliary Canc Ctr, Yonsei Canc Ctr,Dept Surg,Coll Med, Seoul, South Korea
[7] Yonsei Univ, Severance Hosp, Dept Radiat Oncol, Coll Med, Seoul, South Korea
来源
CANCER RESEARCH AND TREATMENT | 2024年 / 56卷 / 01期
关键词
Pancreatic ductal carcinoma; Prognosis; Neoadjuvant therapy; X-ray computed tomography; CA-19-9; antigen; CONSENSUS STATEMENT; CANCER; LEWIS; CHEMOTHERAPY; RESECTION; TUMOR; PHENOTYPE; CA19-9; SERUM;
D O I
10.4143/crt.2023.586
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Purpose Clinical prognostic criteria using preoperative factors were not developed for post-neoadjuvant therapy (NAT) surgery of pancreatic ductal adenocarcinoma (PDAC). We aimed to identify preoperative factors associated with overall survival (OS) in PDAC patients who underwent post-NAT curative-intent surgery and develop risk stratification criteria. Materials and Methods Consecutive PDAC patients who underwent post-NAT curative-intent surgeries between 2007 and 2020 were retrospectively analyzed. Demographic, laboratory, surgical, and histopathologic variables were collected. Baseline, preoperative, and interval changes of computed tomography (CT) findings proposed by the Society of Abdominal Radiology and the American Pancreatic Association were analyzed. Cox proportional hazard analysis was used to select preoperative variables associated with OS. We developed risk stratification criteria composed of the significant preoperative variables, i.e., post-NAT response criteria. We compared the discrimination performance of post-NAT response criteria with that of post-NAT pathological (yp) American Joint Cancer Committee TNM staging system. Results One hundred forty-five PDAC patients were included. Stable or increased tumor size on CT (hazard ratio [HR], 2.58; 95% confidence interval [CI], 1.58 to 4.21; p < 0.001) and elevated preoperative carbohydrate antigen 19-9 (CA19-9) level (HR, 1.98; 95% CI, 1.11 to 3.55; p=0.021) were independent factors of OS. The OS of the patient groups stratified by post-NAT response criteria which combined changes in tumor size and CA19-9 showed significant difference (p < 0.001). Such stratification was comparable to ypTNM staging in discrimination performance (difference of C-index, 0.068; 95% CI, -0.012 to 0.142). Conclusion "Any degree of decrease in tumor size on CT" and CA19-9 normalization or staying normal were independent favorable factors of OS. The combination of the two factors discriminated OS comparably to ypTNM staging.
引用
收藏
页码:247 / 258
页数:12
相关论文
共 50 条
  • [31] Investigating the prognostic value of a panel of biomarkers after curative intent resection of pancreatic ductal adenocarcinoma
    Johnson, Benny
    Khalil, Maged F.
    Blansfield, Joseph
    Lin, Fan
    Zhu, Shaobo
    Kirchner, Lester
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (04)
  • [32] Is There a Role for Routine Specialty Palliative Care Consultation in Cancer Patients Undergoing Curative-Intent Surgery?
    DePeralta, Danielle K.
    ANNALS OF SURGERY, 2021, 274 (06) : E651 - E651
  • [33] Early vs conventional onset pancreatic ductal adenocarcinoma: analysis of surgical and oncologic outcomes in patients undergoing curative intent resection
    Zironda, Andrea
    Zhang, Chi
    Day, Courtney
    Mcwilliams, Robert R.
    Starlinger, Patrick
    Warner, Susanne G.
    Smoot, Rory L.
    Cleary, Sean P.
    Kendrick, Micheal L.
    Thiels, Cornelius A.
    HPB, 2024, 26 (01) : 145 - 153
  • [34] Neoadjuvant therapy for localized pancreatic ductal adenocarcinoma
    Brown, Zachary J.
    Shannon, Alexander H.
    Cloyd, Jordan M.
    MINERVA SURGERY, 2024, : 315 - 325
  • [35] Surgical Margin Status of Patients with Pancreatic Ductal Adenocarcinoma Undergoing Surgery with Radical Intent: Risk Factors for the Survival Impact of Positive Margins
    Lai, Chun-Chi
    Wang, Shang-Yu
    Liao, Chien-Hung
    Hsu, Jun-Te
    Chiang, Kun-Chun
    Yeh, Ta-Sen
    Hwang, Tsann-Long
    Yeh, Chun-Nan
    IN VIVO, 2018, 32 (06): : 1591 - 1597
  • [36] New Persistent Opioid Use Among Patients With Cancer After Curative-Intent Surgery
    Lee, Jay Soong-Jin
    Hu, Hsou Mei
    Edelman, Anthony L.
    Brummett, Chad M.
    Englesbe, Michael J.
    Waljee, Jennifer F.
    Smerage, Jeffrey B.
    Griggs, Jennifer J.
    Nathan, Hari
    Jeruss, Jacqueline S.
    Dossett, Lesly A.
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35 (36) : 4042 - +
  • [37] Clinical impact of margin status on survival and recurrence pattern after curative-intent surgery for pancreatic cancer
    Yamamoto, Takehito
    Uchida, Yoichiro
    Terajima, Hiroaki
    ASIAN JOURNAL OF SURGERY, 2019, 42 (01) : 93 - 99
  • [38] Surveillance patterns after curative-intent colorectal cancer surgery in Ontario
    Tan, Jensen
    Muir, Jennifer
    Coburn, Natalie
    Singh, Simron
    Hodgson, David
    Saskin, Refik
    Kiss, Alex
    Paszat, Lawrence
    El-Sedfy, Abraham
    Grunfeld, Eva
    Earle, Craig
    Law, Calvin
    CANADIAN JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2014, 28 (08) : 427 - 433
  • [39] Impact of Neoadjuvant Chemoradiotherapy on Postoperative Course after Curative-intent Transthoracic Esophagectomy in Esophageal Cancer Patients
    Dirk J. Bosch
    Christina T. Muijs
    Véronique E. M. Mul
    Jannet C. Beukema
    Geke A. P. Hospers
    Johannes G. M. Burgerhof
    John Th. M. Plukker
    Annals of Surgical Oncology, 2014, 21 : 605 - 611
  • [40] Patient surveillance after curative-intent surgery for rectal cancer.
    Longo, WE
    McGarry, AE
    Gammon, SR
    Grossmann, EM
    Virgo, KS
    Ode, K
    Audisio, RA
    Shariff, US
    Papettas, T
    Johnson, FE
    JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 284S - 284S